FDA FOIA Monitor
FDA FOIA Monitor 1.5, Released October 2026
FDA closed 1,449 FOIA requests in September, the most of any month since 2020, while the median wait jumped to 48 days. This issue covers the one filer behind three...
FDA FOIA Monitor 1.5, Released October 2026
FDA closed 1,449 FOIA requests in September, the most of any month since 2020, while the median wait jumped to 48 days. This issue covers the one filer behind three...
FDA FOIA Monitor 1.4, Released Septmber 2026
foiadocs.com · Monthly Intelligence FDA FOIA Monitor Volume 1, Issue 4 · August 2026 Data Through August 31, 2026 Published September 2026 Source: FDA FOIA Log Why is the August...
FDA FOIA Monitor 1.4, Released Septmber 2026
foiadocs.com · Monthly Intelligence FDA FOIA Monitor Volume 1, Issue 4 · August 2026 Data Through August 31, 2026 Published September 2026 Source: FDA FOIA Log Why is the August...
510K Monitor, August 2026
510(k) Monitor: Inaugural Issue foiadocs.com · Monthly Intelligence 510(k) Monitor Volume 1, Issue 1 · Inaugural Edition Data Through August 2026 Published August 2026 Source: FDA FOIA Log + 510(k)...
510K Monitor, August 2026
510(k) Monitor: Inaugural Issue foiadocs.com · Monthly Intelligence 510(k) Monitor Volume 1, Issue 1 · Inaugural Edition Data Through August 2026 Published August 2026 Source: FDA FOIA Log + 510(k)...
FDA FOIA Monitor 1.3 Released August, 2026
FDA FOIA Monitor: July 2026 foiadocs.com · Monthly Intelligence FDA FOIA Monitor Volume 1, Issue 3 · July 2026 Data Through July 31, 2026 Published August 2026 Source: FDA FOIA...
FDA FOIA Monitor 1.3 Released August, 2026
FDA FOIA Monitor: July 2026 foiadocs.com · Monthly Intelligence FDA FOIA Monitor Volume 1, Issue 3 · July 2026 Data Through July 31, 2026 Published August 2026 Source: FDA FOIA...
FDA GLP-1 FOIA Monitor | Ozempic, Wegovy, Zepbo...
Interest in GLP-1 medications has grown rapidly, making them one of the most requested topics under the Freedom of Information Act (FOIA). This page tracks FDA FOIA requests involving semaglutide,...
FDA GLP-1 FOIA Monitor | Ozempic, Wegovy, Zepbo...
Interest in GLP-1 medications has grown rapidly, making them one of the most requested topics under the Freedom of Information Act (FOIA). This page tracks FDA FOIA requests involving semaglutide,...
FDA FOIA Monitor 1.2 Released July 2026
FDA's FOIA office rebounded in June after a slow spring: median processing time dropped 38% in a single month, and the release rate climbed back to 74%. Also this issue:...
FDA FOIA Monitor 1.2 Released July 2026
FDA's FOIA office rebounded in June after a slow spring: median processing time dropped 38% in a single month, and the release rate climbed back to 74%. Also this issue:...